Ensign Group short reports investigation

Pomerantz LLP is investigating claims on behalf of investors of The Ensign Group, Inc. (Nasdaq: ENSG) for potential securities fraud or other unlawful business practices. The investigation follows two short reports published in June 2026. On June 8, 2026, Hunterbrook Media published a report alleging that Ensign Group's business model relies on inadequate patient care and gaming quality metrics, and that profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates, resulting in patient harm. Following this, Ensign's stock price fell 8.15% to $156.42. On June 11, 2026, Muddy Waters Research published a report alleging possible Medicare and Medicaid fraud via a scheme to rent licenses of administrators who are not actually managing facilities, potentially violating the False Claims Act. Ensign's stock fell an additional 2.98% to $147.13. Pomerantz LLP is investigating whether Ensign Group and certain officers/directors engaged in securities fraud.